chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortly after receiving the moderna first shot I began experiencing extreme pain and stiffness in my left hip. By the next day the pain spread to my right hip. 2 days after that I could not move my right arm for the pain and weakness which gradually spread to my left arm where I received the shot.  Both arms are very weak and shakey and burn like fire and are extremely painful when trying to lie down or sleep.  This has been going on ever since March 16, 2021.  I contacted my health care provider and was told to try tumerich and tylenol, none of which helped.  Is there anything I can do to counteract this joint and muscle attack by this vaccine?
1305 - pt. found in post vaccination waiting area pale, diaphoretic, and slightly slumped over.  RN notified.  Rn arrived at pt's. side to find her pale and unfocused, staring with pupils slightly dilated.  No LOC per medic in waiting area.  medic described " 2 minutes of pt. with petite mal seizure activity".  Rn did not observe any tonic seizure activity but pt. very slow to focus and answer questions. 911 notified and pt. placed in wheelchair and moved to Tx. area.  Placed supine, BP 116 palp, HR 100, RR - 28.  O2 started @ 6L by NC.  1310- Med Hx reveals pt. stopped oral Cymbalta 3/5/21.  1312 - Pt. more alert , focused and able to answer questions appropriately.  1315 - medics arrived and care transferred.  BP - 138 palp Glucose - 95.  1320 - pt. remains stable and able to notify family by phone.    !325 - Pt. transported to Hospital by ambulance in stable condition.
Mother states daughter had grand mal seizure this AM at school. No treatment. Was afebrile. Mother states sibling had similar reaction to MMR eyes rolled back, body stiffened, unconscious x 5 min
pt recv vax; facial nerve palsy; weakness of facial muscles & pain; started 7 days p/ vax given;
NUMBNESS ON LEFT SIDE OF BODY (LEG, ARM AND FACE); PINS AND NEEDLES THROUGHOUT THE BODY (INTERMITTENTLY); DIZZINESS; VERTIGO; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included anxiety, and other pre-existing medical conditions included no known drug allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 18-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-MAY-2021, the subject experienced dizziness. On 18-MAY-2021, the subject experienced vertigo. On 19-MAY-2021, the subject experienced numbness on left side of body (leg, arm and face). On 19-MAY-2021, the subject experienced pins and needles throughout the body (intermittently). On 22-MAY-2021, Laboratory data included: Blood test (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness, vertigo, numbness on left side of body (leg, arm and face), and pins and needles throughout the body (intermittently). This report was non-serious.
This spontaneous report was received from a healthcare worker concerning unspecified patients (demographics unknown). The healthcare worker reported that doses of VAQTA (Lot # not reported) which were exposed a supported temperature excursion, continued to be administered to unspecified patients on unspecified dates since 07-AUG-2014. No adverse effect had been reported. This is one of several reports received from the same source. Additional information has been requested.
Red, swollen, warm, tender lump at injection site measuring 7x7 cm.
Very tired; This is a spontaneous report from a contactable other hcp. A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the left arm on 12Jan2021 14:30 at a SINGLE DOSE for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. Concomitant medication included ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]). The patient experienced very tired on 12Jan2021 with outcome of recovering.    Information on the lot/batch number has been requested.
Patient received COVID-19 Vaccination at about 11am.  About 1.5 hours later he stated did not feel well and o2 sats had dropped to 74%.  The facility employees alerted the vaccination staff as they were still in the building.  Vaccination team directed staff to call 9-1-1, but patient is on hospice so they called the hospice nurse instead.  Vaccination team had staff lay patient back down in bed and raise feet above heart.  o2 stats rose back up to 88%.  Hospice nurse arrived and sat with patient.  Patient's physician was contacted.  Patient had returned to baseline within 3 hours and 15 minutes of vaccination.
After first vaccine, I got a blood clot which was left untreated (even though I went to the doctor/ER SEVEN times). I now have to get surgery.
This case was reported by a health care professional and described the occurrence of multiple sclerosis flare in a 33-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included multiple sclerosis. Concurrent medications included REBIF and unknown concurrent medications. On 20 September 2011 at 11:00 the subject received 1st dose of FLULAVAL at 0.5 ml in the right arm. On 23 September 2011, 3 days after vaccination with FLULAVAL, the subject experienced multiple sclerosis flare and was hospitalized overnight. The subject also experienced itching arms, hips and legs with onset 23 September 2011. Painful welts on the arms, legs and hips was also reported (onset date not specified). The healthcare professional considered the events were disabling. At the time of reporting the outcome of the events was unspecified. The subject was discharged from the hospital on 24 September 2011.
Extreme pain at the injection site. Headache and insomnia due to pain. Tylenol not helping.
First Covid-19 Vaccine: flu-like symptoms; First Covid-19 Vaccine: whole left arm muscle was sore; First Covid-19 Vaccine: joint in his elbow was like somebody had a knife sticking in it; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EH9899, first dose) solution for injection intramuscular in the left arm on 28Dec2020 at 08:15 (at the age of 74-years-old) as a single dose for COVID-19 vaccination. Medical history included ongoing severe COPD (chronic obstructive pulmonary disease) from 2014 and ongoing idiopathic pulmonary fibrosis from 2020. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 29Dec2020, after the first Covid-19 vaccine, the patient experienced flu-like symptoms, whole left arm muscle was sore and joint in his elbow was like somebody had a knife sticking in it. There was no emergency room or physician office for the events flu-like symptoms, muscle soreness and joint pain. Treatment for the events muscle soreness and joint pain included acetaminophen (TYLENOL). The outcome of the event flu-like symptoms was recovered in Jan2021, after about 3 days. The outcome of the events muscle soreness and joint pain was recovered in Dec2020, after about 24 hours.
Blood tinged stools x 3-4 in one day (3/11/11) continued for 2-3 days & resolved on it's own without treatment - last episodes of bowel movements were all blood.
Vaccinated with vaccines that were in the fridge for 33 days; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccinated with vaccines that were in the fridge for 33 days) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccinated with vaccines that were in the fridge for 33 days). On 22-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccinated with vaccines that were in the fridge for 33 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Pharmacy received the vaccine box on 19-may-2021 and was put on refrigerator. The expiration date of vaccine box was till 18-jun-2021.Staff did not dispose the vaccine and continued to use the vaccine until  22-jun-2021 morning  for 5 patients. The reporter stated that remaining 25 doses were disposed. No side effect or prior medical history were reported. No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Additional information received and First dose details were added
About 6 days after my daughter received  her routine 12 month shots, she developed hives all over her body. Spots included: belly button, inner thighs, arm pits, eye lids, back of her neck, and torso. I figured it was just a normal reaction to the measles shot so I took her to the pediatrician just to be sure. They informed me it was not a normal reaction to MMR shot, but that it was hives. The told me it was something she came in contact with, food or household items that she was allergic to. However, all the food or other products she has had since then or before that date and never had hives. She had the hives for a fee weeks. We visited the pediatrician twice during that time and the urgent care once due to the hives and a strong fever. Nothing they prescribed worked. They prescribed benadryl and hydrocortisone ointment. Every time we visited for this matter, they said it was nuts, eggs, shellfish, milk. Since she was 12 months, we have given her these food items on a regular basis, weekly, and no hives. Hives have not come back since this time period.
developed blood clots; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received first does of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via unspecified route of administration, on an unspecified date in Apr2021 as DOSE 1, SINGLE for covid-19 immunization. The patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via unspecified route of administration, on an unspecified date in Jul2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date after the first dose of vaccination, the patient experienced developed blood clots. Reporter reported that, the patient developed blood clots after getting both doses of the vaccine. Reporter wanted to know what studies and reports was available of others experiencing the same effect. The outcome of event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the available limited information, a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported event thrombosis cannot be fully assessed/exclude. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
The patient had a Zostavax administered subcutaneously on 09/14/16. He returned the pharmacy two days later (09/16/16) with an enlarged, inflamed, and hot to the touch upper left arm. The affected area also had a rash that had red and elongated streaks and was painful to touch. He stated that he did not have any other systemic symptoms or other issues.
CDC recommends using single-use vials of normal saline to dilute to each vial of the Pfizer vaccine.  Staff member incorrectly used 100 ml bottles of normal saline to reconstitute multiple vials of vaccine each day. Staff member used a new bottle per day, however, and used the correct amount of normal saline to dilute each vial (1.8 ml per vial). We have since corrected this error and also notified local health authorities. Patient has not reported any adverse events to health clinic where error occurred.
Moderate localized swelling and redness to (L) upper arm three days after administration of Tdap.
Lymph nodes and glands in armpit, breast and arm have been inconstant pain; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number; unknown), via an unspecified route of administration in left arm on 18Mar2021 at 16:00 (at the age of 35 years) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer (full thyroidectomy) and the patient was allergic to almonds. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication and unknown if ongoing. The patient had known drug allergy with PERCOCET. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient was not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Jan2021 at 15:00, the patient experienced lymph nodes and glands in arm pit, breast and arm in constant pain for 24 hours after the shot. Therapeutic measures were not taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of lymph nodes and glands in arm pit, breast and arm in constant pain was not resolved at the time of this report. Information about lot/ batch number cannot be obtained. No further information is expected.
Patient developed a localized area of redness, heat and swelling. The patient was treated with Keflex.
Large raised/swollen area at VARIVAX vaccine site - 12 days post vaccine. No fever, no redness. Resolved w/in.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 51-year-old male patient who received FLUARIX QUADRIVALENT (batch number 74BL5, expiry date 30th June 2019) for prophylaxis. Co-suspect products included ADACEL for prophylaxis. On 4th October 2018, the patient received the 1st dose of FLUARIX QUADRIVALENT (intramuscular) and the 1st dose of ADACEL (intramuscular). On 5th October 2018, 1 days after receiving FLUARIX QUADRIVALENT, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to FLUARIX QUADRIVALENT. Additional details were reported as follows: The patient received FLUARIX QUADRIVALENT and ADACEL on the left deltoid. Subsequently, the patient experienced pain in the vaccinated arm. It was sore to the touch and sore upon movement.
Swelling in left hand; Bruise on right knee; big knot on right knee; could not lift left arm; left arm weakness; pain extending from arm pits to breast; Broke out in the bend of my right arm; Itching; A spontaneous report was received from a consumer who is a 61-year old, female patient who received and experienced rash at the bend of right arm, itching, swelling in the left hand, itching on the left hand, itching on the right knee, bruise on the right knee, big knot on right knee, could not lift left arm, left arm weakness, and pain in armpit to breast.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (batch number 025L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 30 Dec 2020, the patient began to break out in the bend of her right arm and experienced itching about 5-6 mins after vaccination. Initial symptoms ended the same day.   On 31 Dec 2020, the patient went to the emergency room because the itching returned.  Treatment for the event included prednisone and hydroxyzine pamoate 25mg. Treatment worked for a while.  On 06 Jan 2021, the patient reported she experienced swelling and itching in the left hand, Itching, a bruise, and a big knot on right knee. She was not able to lift her left arm with left arm weakness and had pain from her arm pits to her breast.   Action taken with mRNA-1273 in response to the events was not reported.   Outcome of the event of rash at the bend of right arm was recovered/resolved on 30 Dec 2020.    The outcome of the events, itching, swelling in the left hand, itching on the left hand, itching on the right knee, bruise on the right knee, big knot on right knee, could not lift left arm, left arm weakness and pain in armpit to breast was unknown.; Reporter's Comments: This case concerns a 61 Y/O F with nonserious events of unexpected pruritus, muscular weakness, limb discomfort, peripheral swelling, joint swelling, contusion and expected axillary pain, rash.  Event onset the same day as first dose mRNA-1273. Treated with prednisone and hydroxyzine. Rash resolved, but other outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Redness at injection site. Small bump at injection site. Soreness of arm. Warm soaks advised. Advised to call office with new or worsening symptoms.
Dizziness; Headache; chest pain; This is a spontaneous report from a non-contactable physician (patient). A 40-year-old female non-pregnant patient received BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), intramuscularly on 23Dec2020 13:00 at a single dose in arm for COVID-19 immunization. Medical history included known allergies: roasted chestnuts. Concomitant medication included ascorbic acid, betacarotene, biotin, calcium carbonate, calcium phosphate, chlorine, colecalciferol, cupric oxide, ferrous fumarate, folic acid, iodine, magnesium oxide, manganese sulfate, molybdenum, nickel sulfate, nicotinamide, pantothenic acid, phosphorus, potassium chloride, pyridoxine hydrochloride, retinol acetate, riboflavin, selenium, silicon, thiamine, tin, tocopherol, vanadium, vitamin b12 nos, zinc oxide (MULTIVITAMINS & MINERALS PLUS LUTEIN) within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced dizziness, headache, chest pain, all on 23Dec2020 21:30. No treatment received for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering. This is a non-serious report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Heart flutter and chest pain. I continue to experience intermittent flutter now and then to this day eversince I got my second COVID shot. I have never experienced anything like it before. I have not sought medical evaluation because I'm scared but I also cannot do anything to resolve it.
Patient is experiencing pain in the arm she received the injection. She states she has a knot at the site as well, along with redness on her arm
This report to VAERS provides the following narrative: A spontaneous report received from consumer via regulatory authority (VAERS), concerns a 15 year old male patient. The patient's concurrent disease included asthenia. The patient's concomitant medications were not provided. On unspecified date, the patient received FLUMIST (intranasal) Lot Number AH2193 and HPV4. The patient experienced VIIth nerve paralysis/facial droop and Guillain-Barre syndrome. The outcome of the VIIth nerve paralysis/facial droop was unknown and at the time of reporting, the Guillain-Barre syndrome was ongoing. CT, MRI, spinal tap, EMG, labs all essentially normal; given 2 doses IVIG. Reporter assessed the Guillain-Barre syndrome to be serious based on hospitalization. Company physician assessed the VIIth nerve paralysis/facial droop to be serious based on hospitalization.
He was tested positive for COVID-19 /He had mild symptoms; Lack of drug effect; He had mild chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (He was tested positive for COVID-19 /He had mild symptoms), DRUG INEFFECTIVE (Lack of drug effect) and CHILLS (He had mild chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced CHILLS (He had mild chills). On 30-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (He was tested positive for COVID-19 /He had mild symptoms) and DRUG INEFFECTIVE (Lack of drug effect). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (He was tested positive for COVID-19 /He had mild symptoms) and CHILLS (He had mild chills) outcome was unknown and DRUG INEFFECTIVE (Lack of drug effect) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Aug-2021, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported.; Sender's Comments: This is a case of Drug ineffective with associated AEs. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing infection and with the occurrence of COVID-19 infection after vaccination, the causality of COVID 19 is assessed as not applicable. Based on the current available information and temporal association between the use of the product and other reported events, a causal relationship cannot be excluded.
Patient started with hacking dry cough and loss of appetite on 09/27/21, worsening shortness of breath that was evaluated with CT PE Protocol. Scan showed large pulmonary embolism in right pulmonary artery, and several small clots in let lower lobe, also covid pneumonia. Patient is now on supplemental oxygen use and anticoagulation therapy.